When should corticosteroids be initiated in alcoholic hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Start Steroids for Alcoholic Hepatitis

Start prednisolone 40 mg daily (or methylprednisolone 32 mg daily) when the patient has severe alcoholic hepatitis defined by Maddrey Discriminant Function (mDF) ≥32 or MELD >20, but only after systematically ruling out contraindications over approximately 5-7 days from admission. 1, 2, 3

Step 1: Confirm Severe Alcoholic Hepatitis

Calculate severity scores to determine treatment eligibility:

  • Maddrey Discriminant Function ≥32 (primary threshold) 4
  • MELD score >20 (alternative threshold) 2
  • Presence of hepatic encephalopathy (regardless of score) 5

The most recent evidence shows corticosteroids provide maximum survival benefit in patients with MELD scores between 25-39, with diminishing returns above MELD 51 where no benefit is observed. 3 This represents the "therapeutic window" where steroids are most effective.

Step 2: Take Time to Screen for Contraindications (Days 1-7)

Do not rush steroid initiation. Recent systematic review data shows the median time from admission to steroid initiation across clinical trials was 6.5 days, allowing proper evaluation. 6 This observation period is critical for:

Absolute Contraindications (Must Resolve Before Starting):

  • Active uncontrolled infection - Screen with blood cultures, urine cultures, ascitic fluid culture and cell count, chest X-ray 5, 2
  • Uncontrolled gastrointestinal bleeding 4
  • Acute kidney injury with creatinine >2.5 mg/dL 2
  • Acute pancreatitis 2
  • Multiorgan failure or shock 2

Important Nuance on Infection:

Infection is present in 20-30% of patients at admission. 1 However, infection after appropriate antibiotic therapy is NOT an absolute contraindication - recent evidence suggests corticosteroids can be initiated once infection is adequately treated. 5, 7 This represents an evolution from older guidelines that considered any infection absolute.

Consider Alternative Therapy If:

  • MELD >51 - steroids show no survival benefit 3
  • Severe ACLF - poor response likelihood 7

Step 3: Observe for Spontaneous Improvement

During the 5-10 day observation period, monitor bilirubin trend. If bilirubin spontaneously declines >10% within 5-10 days, the benefit of corticosteroids becomes uncertain. 8 These patients may have favorable prognosis without steroids, though this remains an area requiring larger studies.

Step 4: Initiate Steroids with Standard Regimen

Once contraindications are ruled out:

  • Prednisolone 40 mg daily for 28 days (most common regimen) 4, 1, 4, 6
  • Methylprednisolone 32 mg daily is equivalent alternative 1, 9
  • Consider adding N-acetylcysteine IV for 5 days - showed 1-month survival benefit in one trial, though not 6-month benefit 1, 5

Step 5: Assess Response at Day 7

Calculate Lille score on day 7 of treatment - this is mandatory for determining whether to continue steroids. 4, 5, 1

  • Lille score <0.45: Continue prednisolone for full 28 days 5
  • Lille score 0.45-0.56: Consider stopping on case-by-case basis 1
  • Lille score ≥0.56 (null responders): Stop steroids immediately 4, 1

Continuing steroids in null responders provides no benefit and only increases infection risk. 4 These patients should be considered for liver transplantation if eligible. 4

Step 6: Taper Regimen

After completing 28 days (in responders):

  • Two-week taper is most commonly used and recommended 6
  • Some protocols use abrupt discontinuation without taper 4
  • Close outpatient follow-up during taper period is essential 6

Critical Monitoring During Treatment

Infections occur in 25% of patients during the first month of steroid treatment, with most occurring early. 1, 6 Maintain high suspicion and low threshold for:

  • Repeat blood/urine/ascitic fluid cultures with any clinical deterioration
  • Fungal infection screening (invasive aspergillosis, pneumocystis) in high-risk patients 9
  • Gastrointestinal bleeding surveillance 6

What NOT to Use

Pentoxifylline is no longer recommended - multiple recent trials and meta-analyses show it does not improve survival alone or in combination with steroids. 1, 5 It should not be used as rescue therapy in steroid non-responders. 4

Anti-TNF agents (infliximab, etanercept) are contraindicated - associated with higher mortality and serious infections. 4, 5

Key Pitfall to Avoid

The most common error is starting steroids too quickly without adequate infection screening. The 5-7 day observation window is not wasted time - it allows proper risk stratification, infection treatment, and identification of patients with spontaneous improvement who may not need steroids at all. 6, 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.